Hap Trading, LLC Corvus Pharmaceuticals, Inc. Call Options Transaction History

Hap Trading, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 12, 2022	SELL	$1.46 - $2.48 $146 - $248	-100 Reduced 0.23%	44,300 $8,000
Q4 2021 Feb 14, 2022	BUY	$2.34 - $5.31 $26,910 - $61,064	11,500 Added 34.95%	44,400 $37,000
Q3 2021 Nov 10, 2021	BUY	$1.89 - $8.53 $62,181 - $280,637	32,900 New	32,900 $9,000

30.4M

1.06M

84.3K

Ticker CRVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,553,500
Market Cap $242M
Description
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The compan...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.